Tine Cuppens

Leuven, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Leveraging Digital Technology and Artificial Intelligence to Describe the Real-World Belgian Chronic Lymphocytic Leukemia Patient Population: The BE-CLLEAR Study.

Leveraging Digital Technology and Artificial Intelligence to Describe the Real-World Belgian Chronic Lymphocytic Leukemia Patient Population: The BE-CLLEAR Study.

Journal: JCO clinical cancer informatics

Published: March 18, 2026

Osimertinib in patients with advanced/metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer - the Belgian ASTRIS data.

Osimertinib in patients with advanced/metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer - the Belgian ASTRIS data.

Journal: Acta clinica Belgica

Published: January 15, 2020

Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors.

Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: July 13, 2017

Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways.

Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways.

Journal: International journal of cancer

Published: May 08, 2017

Establishment and characterization of uterine sarcoma and carcinosarcoma patient-derived xenograft models.

Establishment and characterization of uterine sarcoma and carcinosarcoma patient-derived xenograft models.

Journal: Gynecologic oncology

Published: April 10, 2017

Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group Initiative.

Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group Initiative.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: August 26, 2016

Genomic Characterisation and Response to Trastuzumab and Paclitaxel in Advanced or Recurrent HER2-positive Endometrial Carcinoma.

Genomic Characterisation and Response to Trastuzumab and Paclitaxel in Advanced or Recurrent HER2-positive Endometrial Carcinoma.

Journal: Anticancer research

Published: August 18, 2016

Potential Therapeutic Targets in Uterine Sarcomas.

Potential Therapeutic Targets in Uterine Sarcomas.

Journal: Sarcoma

Published: August 14, 2015

Uterine smooth muscle tumor analysis by comparative genomic hybridization: a useful diagnostic tool in challenging lesions.

Uterine smooth muscle tumor analysis by comparative genomic hybridization: a useful diagnostic tool in challenging lesions.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: August 11, 2014

Growth differentiation factor-15 as biomarker in uterine sarcomas.

Growth differentiation factor-15 as biomarker in uterine sarcomas.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: January 10, 2014

Showing 1-10 of 10

Last Updated: 09/26/2026